In the article, “A Review of the Alleged Health Hazards of Monosodium Glutamate,” by Anca Zanfirescu, Anca Ungurianu, Aristides M. Tsatsakis, George M. Nițulescu, Demetrios Kouretas, Aris Veskoukis, Dimitrios Tsoukalas, Ayse B. Engin, Michael Aschner, and Denisa Margină (Comprehensive Reviews in Food Science and Food Safety, 2019 , Vol. 18, No. 4, pp, 1111–1134, doi: https://doi.org/10.1111/1541-4337.12448), on page 1127, In the 3^rd paragraph on page 17 of the article, the references for (Vellisca & Latorre, 2013) and for (Holton, Taren, Thomson, Bennett, & Jones, 2012) were reversed.

The paragraph should read,

“MSG administration may also impact patients suffering from fibromyalgia. One study reported that the administration of 5 g of MSG, over 3 consecutive days, led to a worsening of fibromyalgia severity, as determined by the revised fibromyalgia impact questionnaire, and a nonsignificant trend toward worsening fibromyalgia pain, as based on a visual analog scale (Holton, Taren, Thomson, Bennett, & Jones, 2012). However, the administration of MSG and aspartame‐free meals, did not improve symptoms of fibromyalgia in a trial enrolling 72 female patients suffering from this disease (Vellisca & Latorre, 2013). The results of the above‐mentioned studies suggest a plausible link between MSG use and pain‐associated conditions.”

在Anca Zanfirescu，Anca Ungurianu，Aristides M. Tsatsakis，George M. Nițulescu，Demetrios Kouretas，Aris Veskoukis，Dimitrios Tsoukalas，Ayse B. Enner，Ayse B. Engin的文章“对谷氨酸钠的所谓健康危害的评论”中。 ，以及DenisaMargină（《食品科学与食品安全综合评论》，2019年，第18卷，第4期，第111-1134页，doi：https：//doi.org/10.1111/1541-4337.12448），第1127页，在3^次文章的第17页上的段落，为（贝利斯卡＆拉托雷，2013）和（霍顿，Taren，汤姆逊，贝内特和琼斯，2012）引用了逆转。

该段应为：

味精的给药也可能影响患有纤维肌痛的患者。一项研究报告称，连续3天服用5 g味精，导致纤维肌痛的严重程度恶化，这是根据修订后的纤维肌痛影响调查表确定的；根据视觉模拟量表，纤维肌痛的恶化趋势无明显变化（霍顿，塔伦，汤姆森，贝内特和琼斯，2012年）。但是，在一项纳入72名患有这种疾病的女性患者的试验中，服用味精和不含阿斯巴甜的膳食并没有改善纤维肌痛的症状（Vellisca＆Latorre，2013）。上述研究结果表明，使用味精与疼痛相关疾病之间存在合理的联系。”